Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

161.95 +1.57 (+0.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 246,438
Open 160.38
Bid (Size) 157.00 (100)
Ask (Size) 168.00 (300)
Prev. Close 160.38
Today's Range 158.99 - 164.22
52wk Range 55.17 - 170.87
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade ↗
The upgraded 74 RS Rating shows that the Chicago area-based home health care firm tops more than 70% of stocks for price performance. 
Via Investor's Business Daily
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout ↗
GeneDx (WGS) shows explosive earnings growth of 1,125% and strong technicals, presenting a high-growth momentum and breakout opportunity. 
Via Chartmill

Performance

YTD
+103.4%
+103.4%
1 Month
+16.1%
+16.1%
3 Month
+24.3%
+24.3%
6 Month
+134.1%
+134.1%
1 Year
+103.4%
+103.4%

More News

Read More
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
Via The Motley Fool
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
Via Benzinga
News headline image
Earnings Scheduled For October 28, 2025 ↗
Via Benzinga
News headline image
GeneDx Hldgs's Earnings: A Preview ↗
Via Benzinga
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock ↗
Via Chartmill
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
News headline image
What Does the Market Think About GeneDx Holdings Corp? ↗
Via Benzinga
News headline image
GeneDx (WGS) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher ↗
Via Chartmill
Topics Earnings
News headline image
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
News headline image
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
From GeneDx
Via Business Wire
News headline image
4 Analysts Assess GeneDx Holdings: What You Need To Know ↗
Via Benzinga
News headline image
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
From GeneDx
Via Business Wire
News headline image
This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
Via Benzinga
News headline image
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case ↗
Via Chartmill
News headline image
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
From GeneDx
Via Business Wire
News headline image
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
From GeneDx
Via Business Wire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 161.95
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 12/04/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.